Report an error   


Submitted: 07 December 2018 Modified: 27 February 2019
HERDIN Record #: R07-CIM-18120711202268

The maternal outcome of preeclamptic women admitted in VSMMC from January 2016 - February 2016 encompassing the following: death, comorbidities, and improvement of outcome.

Alfie Calingacion ,
Francine Jessa Castro,
Don Josef Chiong,
Vanessa Marie Habajab,
Youssry Jaranilla,
Dominic Daniel Ortiz,
Angelique Ramirez,
May Angelie Sierras,
Arianne Bebian Wiersma,
Marianne Kristelle Yara

See More

Abstract: Preeclampsia, a hypertensive disorder of pregnancy, remains a significant contributor to the morbidity and mortality of Filipino mothers. Although several risk factors have been identified universally, there is no available data that shows its incidence and major contributing factors in Cebu City. This study aimed to identify the frequency of specific risk factors such as age, gravida score, age of gestation (preterm, term, posterm), BMI, comorbidities (such as hypertension, bronchial asthma, diabetes mellitus, acquired infections during pregnancy), history of drug use, number of prenatal check-up, history of previous pregnancy, social history (smoking, alcohol use, drug use), family history (hypertension, diabetes, bronchial asthma and cancer) and BP upon admission in our local setting in the hope of raising awareness and subsequently lowering the occurrence of preeclampsia. This study was conducted at Vicente Sotto Memorial Medical Center (VSMMC) where data gathered was tallied and analyzed through SPSS software, via Pearson's Correlation Coefficient. There was a positive correlation seen between improved maternal outcome and the following factors: age of gestation (AOG) (0.01 level of significance), BMI (0.01 level), diabetes mellitus (DM) as a comorbidity and/or complication (0.05 level), and a family history of hypertension (0.05 level). There was a negative correlation seen between maternal mortality and the following factors: SBP (0.05 level), BMI (0.01 level), a family history of hypertension (0.05 level), and improved cases (0.05 level), as well as for fetal mortality and AOG (0.01 level). A larger study population over a longer period of time is recommended to affirm the findings of this study.

Publication Type
Thesis/Dissertations
Thesis Degree
MD
Specialization
Medicine
Publication Date
2016
LocationLocation CodeAvailable FormatAvailability
Cebu Institute of Medicine Fulltext Print Format
1. Cunningham, F. . Williams Obstetrics 24th ed. Philadelphia: Elsevier Science, 2014. 728-730.
2. (2010, November 30). Symptoms of preeclampsia. . Retrieved from: http://www.mayoclinic.org/disease-conditions/preeclampsia/basics/symptoms/con-20031644
3. Williams, P. , Pipkin , F. , Pipkin , F. . "The genetics of pre-eclampsia and other hypertensive disorders of pregnancy" Best Practice & Research. Clinical Obstetrics & Gynecology , 405-417, 2011
4. Eiland, Elosha , Nzerue, Chike , Faulker, Marquetta . "Preeclampsia 2012" Journal of Pregnancy , 1-7, 2012
5. Ronsmans, C. , Graham, W.J. . "Maternal mortality; who, when, where and why" The Lancet , 2006
6. Villar, J. , Say , L. , Gulmezoglu, A.M. , Meraldi, M. , Lindheimer, M.D. , Beltran , A.P. . Elampsia and pre eclampsia : a health problem for 2000 years . In Pre-eclampsia London: RCOG Press, 2003. 189-207.
7. Preeclampsia: A decade of perspective, building a global to action. Preeclampsia Foundation Melbourne, Floridda: 2010.
8. Kuklina, E.V. . "Hypertensive disorders and severe obstetric morbidity in the United States" Obstetrics Gynecology 113, 1299-306, 2009
9. Maternal mortality in 2005: estimates developed by WHO, UNICEF, UNIFPA and the World Bank. World Health Organization Geneva: 2007.
10. Arulkumaran, N. . "Severe pre-eclampsia and hypertensive crises" Best Practice & Research. Clinical Obstetrics & Gynaecology 27(6): 877-884, December 2013
11. Erlebacher, A. . "Immunology of the maternal-fetal interface" Annual Review of Immunology 31, 387, 2013
12. Cunning, F. . Williams Obstetrics 24th ed. United States of America: McGraw Hill, 2014. 773.
13. Williams, P. , Pipkin , F. . "The genetics of pre-eclampsia and other hypertensive disorders of pregnancy" Best Practice & Research. Clinical Obstetrics & Gynaecology , 405-417, 2011
14. Brennecke, S.P. , Gude, N.M , Di Lulio, J.L. , King, R.G. . Clinical Science 9(1): 51-55, 1997
15. Hernandez-Diaz, S. . "Risk of pre-eclampsia in first and subsequent pregnancies: Prospective cohort study" BJM Clinical Research , 2009
16. Kasper , D. L.. Harrison New York: McGraw Hill, 2015.
17. Savita, R. . (2008, November 30). Maternal and perinatal outcome in severe pre-eclampsia and eclampsia. . Retrieved from: http://www.jaypeejournals.com/eJournals/ShowText.aspx?ID=387&Type=FREE &TYP=TOP&IN=eJournals/images/JPLOGO.gif&IID=41&isPDF=NO
18. (2016, November 30). Population of the Philippines (2017 and historical). Worldmeters. . Retrieved from: https://www.worldmeters.info/world-population/philippines-population/Accessed
19. (2013, November 30). Live births in the Philippines: 2014 Philippines Statistics Authority. Philippines Statistics Authority. . Retrieved from: https://psa.gov.ph/live-births-philippines-2014
20. (2016, November 30). Maternal mortality ratio (Modeled estimate, per 100,000 Live births). The World Bank. . Retrieved from: http://data.worldbank.org/indicator/SH.STA.MMRT.
21. Morse, , Mosher, . (2016, November 30). Why do Filipino women die in childbirth?. Population Research Institute. . Retrieved from: https://www.pop.org/content/why-do-filipino-women-die-childbirth.

Copyright © One Window Project 2018. All rights reserved.